154 related articles for article (PubMed ID: 32318637)
1. Assessment of lipid response to acute olanzapine administration in healthy adults.
Nahmias A; Stahel P; Dash S
Endocrinol Diabetes Metab; 2020 Apr; 3(2):e00119. PubMed ID: 32318637
[TBL] [Abstract][Full Text] [Related]
2. A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.
Albaugh VL; Singareddy R; Mauger D; Lynch CJ
PLoS One; 2011; 6(8):e22662. PubMed ID: 21857944
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.
Koller D; Almenara S; Mejía G; Saiz-Rodríguez M; Zubiaur P; Román M; Ochoa D; Navares-Gómez M; Santos-Molina E; Pintos-Sánchez E; Abad-Santos F
Adv Ther; 2021 Feb; 38(2):1035-1054. PubMed ID: 33278020
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
Ballon JS; Pajvani UB; Mayer LE; Freyberg Z; Freyberg R; Contreras I; Rosenbaum M; Leibel RL; Lieberman JA
J Psychopharmacol; 2018 May; 32(5):533-540. PubMed ID: 29444618
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
[TBL] [Abstract][Full Text] [Related]
6. Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
Smith RC; Lindenmayer JP; Hu Q; Kelly E; Viviano TF; Cornwell J; Vaidhyanathaswamy S; Marcovina S; Davis JM
Schizophr Res; 2010 Jul; 120(1-3):204-9. PubMed ID: 20457512
[TBL] [Abstract][Full Text] [Related]
7. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
8. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
[TBL] [Abstract][Full Text] [Related]
9. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
10. Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study.
Vidarsdottir S; Vlug P; Roelfsema F; Frölich M; Pijl H
J Clin Psychiatry; 2010 Sep; 71(9):1205-11. PubMed ID: 20441717
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes.
Tavares G; Marques D; Barra C; Rosendo-Silva D; Costa A; Rodrigues T; Gasparini P; Melo BF; Sacramento JF; Seiça R; Conde SV; Matafome P
Mol Metab; 2021 Sep; 51():101241. PubMed ID: 33933677
[TBL] [Abstract][Full Text] [Related]
12. Effects of olanzapine and haloperidol on the metabolic status of healthy men.
Vidarsdottir S; de Leeuw van Weenen JE; Frölich M; Roelfsema F; Romijn JA; Pijl H
J Clin Endocrinol Metab; 2010 Jan; 95(1):118-25. PubMed ID: 19906788
[TBL] [Abstract][Full Text] [Related]
13. Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.
Almandil NB; Liu Y; Murray ML; Besag FM; Aitchison KJ; Wong IC
Paediatr Drugs; 2013 Apr; 15(2):139-50. PubMed ID: 23519708
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls.
Hahn MK; Wolever TM; Arenovich T; Teo C; Giacca A; Powell V; Clarke L; Fletcher P; Cohn T; McIntyre RS; Gomes S; Chintoh A; Remington GJ
J Clin Psychopharmacol; 2013 Dec; 33(6):740-6. PubMed ID: 24100786
[TBL] [Abstract][Full Text] [Related]
15. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease.
Teff KL; Rickels MR; Grudziak J; Fuller C; Nguyen HL; Rickels K
Diabetes; 2013 Sep; 62(9):3232-40. PubMed ID: 23835329
[TBL] [Abstract][Full Text] [Related]
17. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Markianos M; Hatzimanolis J; Lykouras L
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
[TBL] [Abstract][Full Text] [Related]
19. Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.
Martin WF; Correll CU; Weiden PJ; Jiang Y; Pathak S; DiPetrillo L; Silverman BL; Ehrich EW
Am J Psychiatry; 2019 Jun; 176(6):457-467. PubMed ID: 30845818
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
